Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 2, 2000, Pages 919-922

  Cohen, R ^a   Campos, J M ^a   Salaun C ^a   Heshmati, H M ^a   Kraimps, J L ^a   Proye, C ^a   Sarfati, E ^a   Henry, J F ^a   Niccoli Sire, P ^a   Modigliani, E ^a  

^a AVICENNE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; PENTAGASTRIN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CALCITONIN BLOOD LEVEL; CHILD; COMORBIDITY; FEMALE; FRANCE; HUMAN; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MULTIPLE ENDOCRINE NEOPLASIA; NECK DISSECTION; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SURGICAL TECHNIQUE; THYROID MEDULLARY CARCINOMA; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CALCITONIN; CARCINOMA, MEDULLARY; CHILD; CHILD, PRESCHOOL; FEMALE; FORECASTING; HUMANS; IMMUNORADIOMETRIC ASSAY; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; REFERENCE VALUES; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 17744381151     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.2.919     Document Type: Article

References (22)

1. Epithélioma de la thyroïde sécrétant de la thyrocalcitonine
2. Les cancers médullaires en France en 1995
3. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
4. Genetic testing in medullary thyroid carcinoma syndromes: Mutation types and clinical significance
5. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: Results in 899 patients
6. Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients
7. Medullary thyroid carcinoma: Clinicopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970
8. Prognostic factors in medullary thyroid carcinoma: Evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register
9. Medullary thyroid carcinoma: Prognosis of familial versus sporadic disease and the role of radiotherapy
10. Results of long-term continuous subcutaneous octreotide administration in 14 patients with medullary thyroid carcinoma
11. Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine
12. Les cancers à calcitonine: Définition, historique, différentes formes
13. Diagnosis of medullary carcinoma of the thyroid (MCT) by calcitonin assay using monoclonal antibodies: Criteria for the pentagastrin stimulation test in hereditary MCT
14. Sporadic medullary microcarcinoma of the thyroid: A retrospective analysis of eighty cases
15. Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma
16. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A
17. Interest of routine measurement of serum calcitonin: Study in a large series of thyroidectomized patients
18. The prognostic value of calcitonin immunostaining in medullary carcinoma of the thyroid
19. Immunohistochemical study of calcitonin gene-related peptide in human medullary carcinoma and C cell hyperplasia
20. The secretory process of the adult mouse thyroid "C" cells and the establishment of the secretory period during the foetal life
21. Calcitonin gene family of peptides
22. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: Comparison with genetic screening in hereditary medullary thyroid carcinoma